Abstract
The contribution of T cells to the pathogenesis of rheumatoid arthritis (RA) has been a matter of debate which is addressed in a number of reviews and chapters of this book 1-3. The contribution of monocytes through the production of proinflammatory cytokines has been simpler to demonstrate 4. Accordingly, Interleukin (IL)-1 and tumor necrosis factor (TNF)a have been selected as important therapeutic targets 5.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Firestein GS, Zvaifler NJ (1990) How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33: 768–772
Panayi GS, Lanchbury JS, Kingsley GH (1992) The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35: 729–735
Fox D (1997) The role of T cells in the immunopathogenesis of rheumatoid arthritis. Arthritis Rheum 40: 598–609
Arend WP, Dayer JM (1995) Inhibition of the production and effects of Interleukin1 and Tumor Necrosis Factor a in rheumatoid arthritis. Arthritis Rheum 38: 151–160
Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105–1110
Firestein GS, Alvaro-Gracia J, Maki R (1990) Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144: 3347–3353
Miossec P (1993) Acting on the cytokine balance to control auto-immunity and chronic inflammation. Eur Cytokine Netw 4: 245–251
Miossec P, Chomarat P, Dechanet J (1996) Bypassing the antigen to control rheumatoid arthritis. Immunol Today 17: 170–173
Chen E, Keystone EC, Fish EN (1993) Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 36: 901–910
Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787–793
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of activities and secreted proteins. J Immunol 136: 2348–2357
Mosmann TR, Schumacher JH, Street NF, Budd R, O’Garra A, Fong TAT, Bond MW, Moore KWM, Sher A, Fiorentino DF (1991) Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 123: 209–229
Romagnani S (1991) Human TH1 and TH2 subsets: doubt no more. Immunol Today 12: 256–257
Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88: 346–350
Miltenburg AMM, Van Laar JM, De Kuiper R, Daha MR, Breedveld FC (1992) T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 35: 603–610
Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Ferre O, Natvig JB (1993) Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 38: 75–82
Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonelli C, Emmi L, De Carli M, Tiri A, Ricci M, Romagnani S (1991) Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 146: 1169–1174
Salmon Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, Birembaut P, Maquart FX (1996) Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol 132: 802–806
Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24: 328–332
Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet J-C, Arlacon-Segovia D, Galanaud P, Emilie D (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181: 839–844
Mauri C, Williams RO, Walmsley M, Feldmann M (1996) Relationship between Thl/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26: 1511–1518
Chomarat P, Kjeldsen-Kragh J, Quayle AJ, Natvig JB, Miossec P (1994) Different cytokine production profiles of 78 T cell clones. Relation to inflammatory arthritis. Eur J Immunol 24: 2087–2091
Chomarat P, Banchereau J, Miossec P (1995) Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 38: 1046–1054
de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209–1220
de Waal Malefyt R, Figdor CG, de Vries JE (1993) Effects of interleukin 4 on monocyte functions: comparison to interleukin 13. Res Immunol 144: 629–633
Isomaki P, Luukkainen R, Toivanen P, Punnonen J (1996) The presence of interleukin13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 39: 1693–1702
Dechanet J, Merville P, Durand I, Banchereau J, Miossec P (1995) The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest 95: 456–463
Zurawski SM, Chomarat P, Djossou, Bidaud C, McKenzie AN, Miossec P, Banchereau J, Zurawski G (1995) The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270: 13869–13878
Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ (1995) Human IL-17: A novel cytokine derived from T cells. J Immunol 155: 5483–5486
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S (1996) T cell Interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183: 2593–2603
Chomarat P, Rissoan M-C, Banchereau J, Miossec P (1993) Interferon y inhibits interleukin-10 production by monocytes. J Exp Med 177: 523–527
Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni M-P, Rugiu FS, De Carli M, Ricci M, Romagnani S (1992) Reciprocal regulatory effects of IFN-y and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148: 2142–2147
Szabo SJ, Dighe AS, Gubler U, Murphy KM (1997) Regulation of the Interleukin-12R 132 subunit expression in developing T helper 1 and Th2 cells. J Exp Med 185: 817–824
Groux H, Sornasse T, Cottrez F, de Vries JE, Coffman RL, Roncarolo MG, Yssel H (1997) Induction of human T helper cell type 1 differentiation results in loss of IFNgamma receptor beta-chain expression. J Immunol 158: 5627–5631
Gause WC, Urban JF, Linsley P, Lu P (1995) Role of B7 signaling in the differentiation of naive CD4* T cells to effector interleukin-4-producing T helper cells. Immunol Res 14: 176–188
Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14: 233–258
Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA (1997) CD28 costimulation promotes the production of Th2 cytokines. J Immunol 158: 658–665
Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA (1995) Differential effects of anti-B7–1 and anti-B7–2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181: 1145–1155
Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW (1995) CD28–B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 155: 4521–4524
Natesan M, Razi Wolf Z, Reiser H (1996) Costimulation of IL-4 production by murine B7–1 and B7–2 molecules. J Immunol 156: 2783–2791
Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG, Nadler LM (1995) B7–1 and B7–2 do not deliver identical costimulatory signals, since B7–2 but not B7–1 preferentially costimulates the initial production of IL-4. Immunity 2: 523–532
Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, Ihle JN (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171–174
Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL (1994) An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 1701–1706
Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S (1996) Essential role of Stat6 in IL-4 signalling. Nature 380: 627–630
Zheng W-P, Flavell RA (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587–596
Kubo M, Ransom J, Webb D, Hashimoto Y, Tada T, Nakayama T (1997) T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STATE. Embo J 16: 4007–4020
Miossec P, Elhamiani M, Chichehian B, Dupuy d’Angeac A, Sany J, Hirn M (1990) Interleukin 2 (IL-2) inhibitor in rheumatoid synovial fluid: correlation with prognosis and soluble IL 2 receptor levels. J Clin Immunol 10: 115–120
Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J (1992) Interleukin 4 inhibits ex vivo production of proinflammatory cytokines and immunoglobulins by rheumatoid synovitis. Arthritis Rheum 35: 874–883
Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M (1994) Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179: 1517–1527
Yssel H, Shanafelt M-C, Soderberg C, Schneider PV, Anzola J, Peltz G (1991) Borrelia burgdorferi activates a T helper type 1-like T cell subset in lyme arthritis. J Exp Med 174: 593–601
Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 254: 277–279
Haanen JBAG, de Waal Malefyt R, Res PCM, Kraakman EM, Ottenhoff THM, de Vries RRP, Spits H (1991) Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 174: 583–592
Iwakura Y, Tosu M, Yoshida E (1991) Induction of inflammatory arthropathy resem-bling rheumatoid arthritis in mice transgenic for HTLV-1. Science 253: 1026–1028
Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B (1997) A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 90: 303–313
Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A (1997) P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385: 81–83
Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE (1994) Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 37: 992–999
Meeusen EN, Premier RR, Brandon MR (1996) Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells? Immunol Today 17: 421–424
Al Janadi M, Al Dalaan A, Al Balla S, Raziuddin S (1996) CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. J Rheumatol 23: 809–814
Chomarat P, Briolay J, Banchereau J, Miossec P (1993) Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4. Arthritis Rheum 36: 234–242
Hart PH, Jones CA, Finlay Jones JJ (1995) Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J Leukoc Biol 57: 909–918
Chomarat P, Vannier E, Dechanet J, Rissoan M-C, Banchereau J, Dinarello CA, Miossec P (1995) The balance of IL-1 receptor antagonist/IL-113 in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154: 1432–1439
Miossec P, Chomarat P, Dechanet J, Moreau J-F, Roux J-P, Delmas P, Banchereau J (1994) Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 37: 1715–1722
Yeh LA, Augustine AJ, Lee P, Riviere LR, Sheldon A (1995) Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol 22: 1740–1746
Van Roon JAG, Van Roy J, Duits A, Lafeber F, Bijlsma JWJ (1995) Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 54: 836–840
Rocken M, Racke M, Shevach EM (1996) IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17: 225–231
Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C (1996) Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 26: 2399–2403
Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D (1990) Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 171: 979–996
Formby B (1995) Immunologic response in pregnancy: Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am 24: 187–205
Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14: 353–356
Raghupathy R (1997) Maternal anti-placental cell-mediated reactivity and spontaneous abortions. Am J Reprod Immunol 37: 478–484
Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. New Engl J Med 329: 466–471
Arasil TK, Tuncer S, Tosun M (1991) Sustained remission of rheumatoid arthritis following hypersensitivity reaction. Arthritis Rheum 34: 789–790
Calabrese LH, Wilke WS, Perkins AD, Tubbs RR (1989) Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren’s syndrome. Arthritis Rheum 32: 1453–1457
Marmont AM (1994) Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune disease? Stem Cells 12: 125–135
Meyaard L, Hovenkamp E, Keet IP, Hooibrink B, de Jong IH, Otto SA, Miedema F (1996) Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. J Immunol 157: 2712–2718
Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL (1993) Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261: 1727–1730
Sieper J, Kary S, Sorensen H, Alten R, Eggens U, Huge W, Hiepe F, Kuhne F, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA (1996) Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial. Arthritis Rheum 39: 41–51
Prakken BJ, van der Zee R, Anderton SM, van Kooten P, Kuis W, van Eden W (1997) Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T-cell epitope in rats supresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci USA 94: 3284–3289
Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94: 10895–10900
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Basel AG
About this chapter
Cite this chapter
Miossec, P. (1998). The Th1/Th2 cytokine balance in arthritis. In: Miossec, P., Firestein, G.S., van den Berg, W.B. (eds) T Cells in Arthritis. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8823-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8823-3_5
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9787-7
Online ISBN: 978-3-0348-8823-3
eBook Packages: Springer Book Archive